Date updated:11-04-2007
No description available

-
KUN
China Shenghuo Ph - $0.66
- -15.38%
- $0.78
No Analysis added

-
SNTA
Synta Pharmaceuti - $6.86
- +6.36%
- $6.61
No Analysis added

-
WAG
Walgreen Co - $27.03
- +1.20%
- $26.45
No Analysis added

-
ORCL
Oracle Corporatio - $17.65
- -4.02%
- $18.02
No Analysis added

-
NED
Noah Education Ad - $3.30
- -3.23%
- $3.48
No Analysis added

-
PFE
Pfizer Inc - $17.49
- -1.74%
- $17.68
No Analysis added

-
CFSG
China Fire & Secu - $7.18
- -14.01%
- $8.31
No Analysis added

-
CHU
China Unicom (hk) - $11.60
- -13.11%
- $11.92
No Analysis added
- Top Professional Portfolios
- 1. Charlie Munger
- 2. Bernard L. Madoff Inve...
- 3. Renaissance Technologies
- 4. Templeton World A (TEMWX)
- 5. Fidelity Select Consum...
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » HMH1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...
At Stockpickr.com, we strive to keep track of insider purchasing and buybacks each week. Here's the perfect setup in my mind: insiders buying the stock, the company buying ...
The traders of CNBC’s "Fast Money" think the current stock market is a traders' market. In order to play a traders' market, you have to nimble. You also have to know whic...
Pfizer (PFE) CEO Jeff Kindler has hinted that the world’s biggest drugmaker is open to a large-scale acquisition. “The real goal is to grow revenues," he told the Fina...
A. small trading before thrusday
These stocks were downgraded by TheStreet.com Ratings on Dec. 29, 2008. more
Here is the stock list of some of the largest % losers from Jan. 7, 2009. more
This portfolio consists of NYSE stocks that are trading for less than $5 per share and are profitable. more








Comments not available